Skip to main content

PeptideFire

Compound Comparisons & Stacks

The Compound Comparisons and Stacks category covers how research peptides stack up against each other and which combinations make sense for different research goals. Posts compare GLP-1 agonists like Tirzepatide vs Semaglutide vs Retatrutide, GHRH analogs like Sermorelin vs CJC-1295, and proven stacks like BPC-157 plus TB-500 for regenerative research. We also cover when single compounds work better than blends, what mechanisms overlap, and where the combined research data actually supports stacking. Use this category to design smarter protocols and avoid pairing compounds that cancel each other out instead of complementing each other.

Compound Comparisons & Stacks PT-141 Profile (Bremelanotide)
Jun 20, 2026

PT-141 Profile (Bremelanotide)

PT-141 (Bremelanotide) activates brain-level melanocortin receptors for sexual arousal. Heres how it works, dosing, side effects, and how it differs...

Compound Comparisons & Stacks CJC-1295 + Ipamorelin Profile
Jun 14, 2026

CJC-1295 + Ipamorelin Profile

CJC-1295 + Ipamorelin is the classic GH peptide stack. 100/200 mcg, 12 week cycle, lean muscle + deep sleep without...

Compound Comparisons & Stacks Tesamorelin Profile
Jun 10, 2026

Tesamorelin Profile

Tesamorelin is the GHRH analog FDA-approved for visceral fat reduction. 2 mg SubQ before bed, 26-week cycles, IGF-1 monitoring. The...

Clinical Research & Mechanisms MOTS-c Compound Profile: The Mitochondrial Peptide for Metabolic Optimization (2026 Guide)
May 31, 2026

MOTS-c Compound Profile: The Mitochondrial Peptide for Metabolic Optimization (2026 Guide)

MOTS-c compound dossier — the 2015 discovery, AMPK mechanism, animal and early human evidence, side effect profile, dosing protocols, and...